| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/20/2020 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 03/25/2020 |
8-K
| Quarterly results |
| 03/16/2020 |
8-K
| Quarterly results |
| 02/14/2020 |
SC 13G
| First Light Asset Management, LLC reports a 0% stake in Nuvectra Corporation |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
8-K
| Quarterly results |
| 01/31/2020 |
8-K
| Quarterly results |
| 01/15/2020 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 12/31/2019 |
8-K
| Quarterly results |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2019 |
4
| HAWARI KENNETH G (Director) has filed a Form 4 on Nuvectra Corp|
Txns:
| Exercised 968 shares
@ $0.11, valued at
$106.5
Exercised 968 options to buy
@ $0 |
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 12/16/2019 |
4
| Kosharek Jennifer (CFO) has filed a Form 4 on Nuvectra Corp|
Txns:
| Exercised 77 shares
@ $0.13, valued at
$10
Exercised 77 options to buy
@ $0 |
|
| 12/09/2019 |
4
| Tranchina Benjamin (Chief Technology Officer) has filed a Form 4 on Nuvectra Corp|
Txns:
| Exercised 4,459 shares
@ $0.16, valued at
$713.4
Exercised 4,459 options to buy
@ $0 |
|
| 12/04/2019 |
4
| HAWARI KENNETH G (Director) has filed a Form 4 on Nuvectra Corp|
Txns:
| Sold 17,000 shares
@ $0.2, valued at
$3.4k
|
|
| 11/25/2019 |
4
| Kosharek Jennifer (CFO) has filed a Form 4 on Nuvectra Corp|
Txns:
| Sold 7,234 shares
@ $0.16, valued at
$1.2k
|
|
| 11/22/2019 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 11/14/2019 |
4
| Kosharek Jennifer (CFO) has filed a Form 4 on Nuvectra Corp|
Txns:
| Exercised 609 shares
@ $0.23, valued at
$140.1
Exercised 609 options to buy
@ $0 |
|
| 11/14/2019 |
8-K
| Quarterly results |
| 11/13/2019 |
GN
| Nuvectra® maintient la prise en charge de ses patients actuels dotés de l'implant Algovita® alors que la société dépose volontairement une requête en vertu du chapitre 11 |
| 11/13/2019 |
GN
| Nuvectra® unterstützt weiterhin bestehende Patienten mit dem Algovita®-Implantat, während das Unternehmen freiwillig ein Verfahren gemäß Chapter 11 beantragt |
| 11/13/2019 |
GN
| Nuvectra®???????11???????Algovita®????????? |
| 11/13/2019 |
GN
| Nuvectra® ???? 11 ?????,????? Algovita® ??????? |
| 11/13/2019 |
GN
| Nuvectra® Terus Mendukung Para Pasien dengan Implan Algovita® Saat Perusahaan Tersebut dengan Sukarela Mengajukan Perlindungan Bab 11 |
| 11/13/2019 |
GN
| ??????11???????????????????Algovita® Implant????????????? |
| 11/13/2019 |
GN
| Nuvectra®, ????? 11? ??? ???? ??? ??? ??, ?? Algovita® ?? ?? ?? ???? ????? ??? ?? |
| 11/13/2019 |
GN
| Nuvectra® Terus Menyokong Pesakit Semasa dengan Implan Algovita® sementara Syarikat Memfailkan Bab 11 secara Sukarela |
| 11/13/2019 |
GN
| Nuvectra® continua a apoiar seus pacientes com o Implante Algovita® enquanto a empresa entra com pedido de recuperação judicial |
| 11/13/2019 |
GN
| Nuvectra® continúa apoyando a los pacientes existentes con el implante Algovita®, mientras la Compañía presenta petición de reestructuración voluntaria bajo el Capítulo XI |
| 11/13/2019 |
GN
| Nuvectra® ????????????????????????????????????????????????????????? Algovita® ??????????????????????????????????????????????????? 11 |
| 11/13/2019 |
8-K
| Quarterly results |
| 11/12/2019 |
GN
| Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11 |
|